Trial · NCT07031115
Linperlisib in the Treatment of aPRCA
NCT07031115, Phase 2, Withdrawn, Peking Union Medical College Hospital
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Linperlisib in the Treatment of aPRCA. Trials, record NCT07031115. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07031115
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Linperlisib in the Treatment of aPRCA
- NCT number
- NCT07031115
- Status
- Withdrawn
- Phases
- Phase 2
- Enrollment
- 0 participants, actual
- Lead sponsor
- Peking Union Medical College Hospital
- Conditions
- Acquired Pure Red Cell Aplasia
- Interventions
- Linperlisib
- First posted
- 2025-06-22
- Last updated
- 2026-11-02
Source ClinicalTrials.gov
Registered outcomes6
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Overall response rate(ORR) | 12weeks | ORR defined as the proportion of patients who met the criteria of either complete response (CR) or partial responce (PR). |
| Primary | Complete response rate (CRR) | 12weeks | CRR defined as the proportion of patients who met the criteria of complete response. |
| Primary | Partial response (PR) | 12weeks | PR defined as the patients who met the criteria of partial responce. |
| Primary | No response (NR) | 12weeks | NR defined as the patients who had transfusion dependence or failed to achieve PR. |
| Secondary | Relapse rate | 12weeks | Relapse rate defined as the proportion of patients whose response shift from PR or CR to NR |
| Secondary | Adverse events | 12weeks | Safety analyses include the incidence, severity grading, and dose relationship of adverse events, along with the proportion of treatment discontinuations or dose reductions due to toxicity. All adverse events that occurred or worsened during the treatment period will be reported, including those occurred later but are considered by the investigator to be related to the trial drug. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers10
The papers the trial lists on ClinicalTrials.gov.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07031115
GET https://conductscience.org/api/trials/v1/NCT07031115/registered